Combined factor IX and protein C deficiency in a child: Thrombogenic effects of two factor IX concentrates
- 1 February 1995
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 48 (2) , 120-124
- https://doi.org/10.1002/ajh.2830480210
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Purified factor IX using monoclonal immunoaffinity technique: clinical trials in hemophilia B and comparison to prothrombin complex concentratesBlood, 1992
- Properties of a Highly Punified Human Plasma Factor IX:c Therapeutic Concentrate Prepared by Conventional ChromatographyVox Sanguinis, 1989
- Immunoaffinity purification of factor IX from commercial concentrates and infusion studies in animalsBlood, 1988
- Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiencyBlood, 1988
- Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity.Proceedings of the National Academy of Sciences, 1985
- Congenital protein C deficiency and thrombotic disease in nine French families.BMJ, 1984
- Congenital Protein C Deficiency and Venous ThromboembolismNew England Journal of Medicine, 1983
- Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzymeBlood, 1982
- Deficiency of protein C in congenital thrombotic disease.Journal of Clinical Investigation, 1981
- Human Plasma Protein CJournal of Clinical Investigation, 1979